A detailed history of Northern Trust Corp transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 95,997 shares of STTK stock, worth $370,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,997
Previous 82,023 17.04%
Holding current value
$370,548
Previous $584,000 46.92%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$7.37 - $10.09 $102,988 - $140,997
13,974 Added 17.04%
95,997 $858,000
Q4 2023

Feb 13, 2024

BUY
$1.37 - $7.24 $19,121 - $101,048
13,957 Added 20.51%
82,023 $584,000
Q3 2023

Nov 13, 2023

SELL
$1.42 - $3.16 $3,055 - $6,800
-2,152 Reduced 3.06%
68,066 $103,000
Q2 2023

Aug 11, 2023

BUY
$2.52 - $3.66 $11,410 - $16,572
4,528 Added 6.89%
70,218 $219,000
Q1 2023

May 15, 2023

BUY
$2.5 - $4.72 $9,157 - $17,289
3,663 Added 5.91%
65,690 $193,000
Q4 2022

Feb 13, 2023

SELL
$1.96 - $3.26 $217 - $361
-111 Reduced 0.18%
62,027 $142,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.52 $15,444 - $32,788
5,940 Added 10.57%
62,138 $167,000
Q2 2022

Aug 12, 2022

SELL
$2.7 - $4.59 $525,611 - $893,539
-194,671 Reduced 77.6%
56,198 $228,000
Q1 2022

May 13, 2022

SELL
$4.22 - $8.89 $82,302 - $173,381
-19,503 Reduced 7.21%
250,869 $1.07 Million
Q4 2021

Feb 08, 2022

BUY
$8.36 - $21.08 $53,077 - $133,836
6,349 Added 2.4%
270,372 $2.3 Million
Q3 2021

Nov 15, 2021

BUY
$17.57 - $28.95 $204,128 - $336,341
11,618 Added 4.6%
264,023 $5.38 Million
Q2 2021

Aug 13, 2021

BUY
$24.14 - $37.68 $2.65 Million - $4.13 Million
109,704 Added 76.88%
252,405 $7.32 Million
Q1 2021

May 12, 2021

SELL
$27.92 - $52.5 $206,021 - $387,397
-7,379 Reduced 4.92%
142,701 $4.17 Million
Q4 2020

Feb 11, 2021

BUY
$19.0 - $57.61 $2.85 Million - $8.65 Million
150,080 New
150,080 $7.87 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $164M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.